Navigation Links
Researchers Present 'a Novel, Automated, Efficient Environmental Disinfection Technology that Significantly Reduces C. difficile, VRE and MRSA Contamination'
Date:10/12/2009

SAN FRANCISCO, Oct. 12 /PRNewswire/ -- In a study presented at the 49th Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), researchers used a mobile, automated UV device to decontaminate hospital rooms at the Cleveland Veterans Affairs (VA) Medical Center in Ohio and analyzed its ability to remove troublesome bacteria, including C. difficile spores. The device, known as Tru-D, uses reflected UVC germicidal energy to decontaminate air and surfaces, including those in primary shadows. Tru-D is manufactured by Lumalier in Memphis, Tennessee.

Curtis Donskey, MD, Chair of the Infection Control Committee at the Cleveland VA Medical Center, concluded that Tru-D is a "novel method for cleaning hospital rooms...easy to use...and more effective than standard disinfection for removing hardy bacteria. The Tru-D device was able to decontaminate all surfaces in 40 hospital rooms, including hard-to-clean surfaces such as the undersides of tables." 18% of sites under the edges of bedside tables were still contaminated with MRSA after routine hospital cleaning, versus 0% after Tru-D use. Research revealed that disinfection with Tru-D reduced the frequency of positive MRSA and VRE cultures by 89%.

"C. difficile spores are especially challenging for hospital staff," Dr. Donskey said. On inoculated surfaces, application of Tru-D using the "spore" setting consistently reduced recovery of C. difficile spores and MRSA by >2-3 logs. Similar VRE reduction was achieved in about half the time using a lower dose setting. "The UV device is computerized and can assess how much is needed for decontamination by measuring the reflected UV radiation from surfaces in the room," stated Donskey. "It's inexpensive to operate and requires no cleaning supplies." After viewing results, Dr. Donskey requested the purchase of several Tru-D units for the Cleveland VA Medical Center.

Other researchers agreed. "UVC radiation is an exciting new technology for disinfecting patient rooms and contaminated surfaces in healthcare," said Luke Chen, MBBS, FRACP, assistant professor of medicine in the Division of Infectious Diseases at Duke University Medical Center. "The Tru-D device demonstrated consistency and rapidity in killing microorganisms," Dr. Chen explained. "There is potential to use this technology to rapidly clean and turn around patient rooms, clinic space or waiting rooms."

John Boyce, MD, chief of the Infectious Diseases Section at the Hospital of Saint Raphael and clinical professor of medicine at Yale University School of Medicine, added, "The advantages of the Tru-D device are that it is easy to employ and that it can reduce the number of positive bacterial cultures substantially."

Dr. Boyce authored a 2008 disinfection study of vaporized hydrogen peroxide, a technology requiring specially-trained operators and 4 to 6 hours to clean a room. "The UV radiation device has the potential to be effective, faster, and less expensive to operate," stated Boyce.

Results presented by Dr. William Rutala PhD., M.P.H., at the 2009 APIC Conference (Association of Professionals in Infection Control and Epidemiology) showed similar results; a consistent 3.91 Log10 reduction for MRSA, 3.36 Log10 reduction for VRE, 3.77 Log10 reduction for Acinetobacter, and 2.67 Log10 reduction for C. difficile. Dr. Rutala's APIC presentation can be found at http://www.disinfectionandsterilization.org.

Tru-D inventor Jeffrey L Deal, MD, FACS, DTMH, refined this advanced disinfection solution over a ten-year span, working closely with Lumalier to insure that Tru-D technology is readily available for broad deployment.

Contact: Chuck Dunn at 800-774-5771, ChuckDunn@lumalier.com, or http://www.lumalier.com

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.

SOURCE Lumalier Corporation


'/>"/>
SOURCE Lumalier Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Researchers create smaller and more efficient nuclear battery
2. Researchers Use Oragene●DNA to Find Genetic Link to Neglected Tropical Disease
3. Researchers prolong the plasma half-life of biopharmaceutical proteins
4. Researchers design new graphene-based, nanomaterial with magnetic properties
5. Argonne Researchers Develop Method that Aims to Stabilize Antibodies
6. Researchers design new graphene-based, nano-material with magnetic properties
7. ChemBridge Corporation and Collaborative Drug Discovery Announce Strategic Collaboration to Provide Diverse Chemical Libraries Together With Researchers Own Private Data
8. Dartmouth researchers propose new way to reproduce a black hole
9. Nucleix Researchers Discover DNA Evidence May Easily be Falsified: Company Develops New Detection Technology for Preventing Biological Identity Theft
10. K-States Biosecurity Research Institute Gives Researchers the Tools Needed to Study Diseases That Cost Pig Producers Hundreds of Millions of Dollars Each Year
11. Sigma-Aldrich Acquires ChemNavigator, Inc., to Provide Researchers With Industry-Leading Chemical Compound Selection and Procurement Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... , ... January 19, 2017 , ... ... product vigilance software to leading biopharmaceutical and medical device manufacturers and regulators, is ... fully 21 CFR Part 11-compliant email client designed to provide product vigilance departments ...
(Date:1/19/2017)... AquaBounty Technologies, Inc. (AIM: ABTU; NASDAQ: AQB), ... and a majority-owned subsidiary of Intrexon Corporation (NYSE: ... listing of its common shares on the NASDAQ Stock ... "AquaBounty,s listing on NASDAQ represents an important milestone ... the U.S. markets as we advance plans for commercial ...
(Date:1/19/2017)... ... January 19, 2017 , ... FireflySci Inc. is a ... The tremendous growth is accounted to two main factors. The first is ... expanding network of vendors supplying FireflySci products all around the world. , 2016 was ...
(Date:1/19/2017)... -- Northwest Biotherapeutics, Inc. (OTCQB: NWBO) ("NW Bio"), a U.S. ... and inoperable solid tumor cancers, announced today that Dr. ... Bio, will present at the Phacilitate Immunotherapy World Conference ... Hotel in Miami, Florida . ... Therapeutic Approaches – Expanding the Reach of Cancer Immunotherapy ...
Breaking Biology Technology:
(Date:12/19/2016)... TORONTO , 19 de diciembre de 2016  Mosaic Biomedicals ... el desarrollo acelerado de MSC-1, un anticuerpo humanizado que se espera ... en 2017, con múltiples sitios previstos a lo largo de Europa ... MSC-1 ... factor inhibidor de leucemia (LIF), una citoquina pleiotrópica que se sobreexpresa ...
(Date:12/15/2016)... FREMONT, Calif. , Dec. 15, 2016   ... a publicly held genomics technology company, announced today that ... the Listing Qualifications Department of The Nasdaq Stock Market ... the closing bid price of WaferGen,s common stock had ... days.  Accordingly, WaferGen has regained compliance with Listing Rule ...
(Date:12/12/2016)... Dec. 12, 2016  Researchers at Trinity College, ... graphene by combining the material with Silly Putty. The ... pressure detector able to sense pulse, blood pressure, ... spider.  The research team,s findings ... read here:  http://science.sciencemag.org/content/354/6317/1257 ...
Breaking Biology News(10 mins):